Nigel Peter Symss1, Shizuo Oi. 1. Division of Pediatric Neurosurgery, Global Neurosciences, Global Health City, Cheran Nagar, Perumbakkam, Sholinganallur Road, Chennai, 600 100, Tamil Nadu, India, nigelpetersymss@gmail.com.
Abstract
OBJECT: The goal of this study is to evaluate whether an "ideal shunt" exists. METHODS: This is a retrospective analysis based on original papers in the field of Hydrocephalus and Shunts. Patients of all age groups, who had hydrocephalus, and underwent some form of CSF diversion were included. The study has been divided into four stages: from 1900 to 1949, 1950 to 1974, 1975 to 1999, and from 2000 to 2010. RESULTS: In stage 1 (historical era): Saphenous vein grafts, rubber conduits, and other materials were used in CSF diversions. In 1949, the first implantable shunt tube was developed by Nulsen. In stage 2 (experimental stage): the Holter valve was developed. Newer innovations were developed in relation to the ventriculo-atrial shunt, which was the preferred CSF diversion. In stage 3 (developmental stage), a large number of different design shunt systems were developed, with the aim of reducing complications. The ventriculo-peritoneal shunt had become the preferred CSF diversion. Also, the programmable valve was born. In stage 4 (era of programmable valve, there is a preference for the use of programmable shunt systems. However, shunt failure rate at 1 year being around 25 to 40%, and shunt survival at 1 and 2 years are 50-70 and 47-53% in most series. CONCLUSION: Every shunt is an ideal shunt provided the choice of the shunt used should be made by the matching performance of the shunt system to the altered profile of CSF dynamics of a given patient. The most important factor being the opening pressure.
OBJECT: The goal of this study is to evaluate whether an "ideal shunt" exists. METHODS: This is a retrospective analysis based on original papers in the field of Hydrocephalus and Shunts. Patients of all age groups, who had hydrocephalus, and underwent some form of CSF diversion were included. The study has been divided into four stages: from 1900 to 1949, 1950 to 1974, 1975 to 1999, and from 2000 to 2010. RESULTS: In stage 1 (historical era): Saphenous vein grafts, rubber conduits, and other materials were used in CSF diversions. In 1949, the first implantable shunt tube was developed by Nulsen. In stage 2 (experimental stage): the Holter valve was developed. Newer innovations were developed in relation to the ventriculo-atrial shunt, which was the preferred CSF diversion. In stage 3 (developmental stage), a large number of different design shunt systems were developed, with the aim of reducing complications. The ventriculo-peritoneal shunt had become the preferred CSF diversion. Also, the programmable valve was born. In stage 4 (era of programmable valve, there is a preference for the use of programmable shunt systems. However, shunt failure rate at 1 year being around 25 to 40%, and shunt survival at 1 and 2 years are 50-70 and 47-53% in most series. CONCLUSION: Every shunt is an ideal shunt provided the choice of the shunt used should be made by the matching performance of the shunt system to the altered profile of CSF dynamics of a given patient. The most important factor being the opening pressure.
Authors: James L Frazier; Paul P Wang; Salil H Patel; Jane E Benson; Duke E Cameron; Alexander H Hoon; Anthony M Avellino Journal: Neurosurgery Date: 2002-09 Impact factor: 4.654
Authors: Sara Iglesias; Bienvenido Ros; Álvaro Martín; Antonio Carrasco; Miguel Segura; Andrea Delgado; Francisca Rius; Miguel Ángel Arráez Journal: Childs Nerv Syst Date: 2016-08-05 Impact factor: 1.475
Authors: Andrés Segura-Hernández; Fernando Hakim; Juan F Ramón; Enrique Jiménez-Hakim; Juan A Mejía-Cordovez; Diego Quintero-Rueda; Yessid Araque-Puello; Camila Pedraza-Ciro; Juan P Leal-Isaza; Juliana Mendoza-Mantilla; Vanesa Robles; Martina Gonzalez; Daniel Jaramillo-Velásquez; Diego F Gómez Journal: Surg Neurol Int Date: 2021-10-19
Authors: Luis Garegnani; Juan Va Franco; Agustín Ciapponi; Virginia Garrote; Valeria Vietto; Santiago Adalberto Portillo Medina Journal: Cochrane Database Syst Rev Date: 2020-06-16